Continuous Renal Replacement Therapy in Critically Ill Children

被引：2
作者：
Demirkol, Demet [1 ]
机构：
[1] Istanbul Univ, Istanbul Fac Med, Dept Pediat Intens Care, Pediat Intens Care, Istanbul, Turkey
来源：
TURKISH ARCHIVES OF PEDIATRICS | 2022年 / 57卷 / 05期
关键词：
Sepsis; respiratory failure; extracorporeal treatment; ACUTE KIDNEY INJURY; CONTINUOUS VENOVENOUS HEMOFILTRATION; VASCULAR ACCESS; CATHETER; SEPSIS; ANTICOAGULATION; MULTICENTER; PREDILUTION; DYSFUNCTION; INITIATION;
D O I：
10.5152/TurkArchPediatr.2022.22082
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Continuous renal replacement therapy is an extracorporeal blood purification therapy that aims to support kidney and other organ functions over an extended period. The high-quality continuous renal replacement therapy requires understanding basic mechanisms of clearance, factors influencing these processes, and the appropriate selection of treatment candidates. This article reviews the different aspects of continuous renal replacement therapy in critically ill pediatric patients.
引用
收藏
页码：489 / 497
页数：9
相关论文
共 59 条
  • [1] [Anonymous], TURKIYEDE SUREKLI RE
  • [2] A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury
    Atan, Rafidah
    Peck, Leah
    Prowle, John
    Licari, Elisa
    Eastwood, Glenn M.
    Storr, Markus
    Goehl, Hermann
    Bellomo, Rinaldo
    [J]. CRITICAL CARE MEDICINE, 2018, 46 (10) : E988 - E994
  • [3] Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs
    Bai, Ming
    Zhou, Meilan
    He, Lijie
    Ma, Feng
    Li, Yangping
    Yu, Yan
    Wang, Pengbo
    Li, Li
    Jing, Rui
    Zhao, Lijuan
    Sun, Shiren
    [J]. INTENSIVE CARE MEDICINE, 2015, 41 (12) : 2098 - 2110
  • [4] Barbar SD, 2018, NEW ENGL J MED, V379, P1431, DOI [10.1056/NEJMoa1803213, 10.1056/nejmoa1803213]
  • [5] Assessment of a renal angina index for prediction of severe acute kidney injury in critically ill children: a multicentre, multinational, prospective observational study
    Basu, Rajit K.
    Kaddourah, Ahmad
    Goldstein, Stuart L.
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (02) : 112 - 120
  • [6] Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413
  • [7] Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose
    Bellomo, Rinaldo
    Martensson, Johan
    Lo, Serigne
    Kaukonen, Kirsi-Maija
    Cass, Alan
    Gallagher, Martin
    [J]. BLOOD PURIFICATION, 2016, 41 (1-3) : 11 - 17
  • [8] Borg Roberta, 2017, J Intensive Care Soc, V18, P184, DOI 10.1177/1751143717695835
  • [9] Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk A Randomized Clinical Trial
    Choi, Ji-Young
    Kang, Yun-Jeong
    Jang, Hye Min
    Jung, Hee-Yeon
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Chan-Duck
    [J]. MEDICINE, 2015, 94 (52)
  • [10] Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure
    Chua, Horng-Ruey
    Baldwin, Ian
    Bailey, Michael
    Subramaniam, Ashwin
    Bellomo, Rinaldo
    [J]. JOURNAL OF CRITICAL CARE, 2012, 27 (06)
123456